Founded with the mission to advance the application of proteomics, Applied Proteomics focuses on developing innovative protein biomarker discovery platforms. Their core product, the SimpliPro Colon™ Test, is a protein-based diagnostic blood test designed to assist healthcare providers in evaluating colorectal health. This test integrates seamlessly into routine medical examinations, aiming to enhance early detection and improve patient outcomes in colorectal cancer.
Notable figures associated with Applied Proteomics include experts in proteomics and diagnostics, though specific names are not provided. The company has made significant strides in the field of protein-based diagnostics, with the SimpliPro Colon™ Test being a key achievement. This test has the potential to significantly impact colorectal cancer screening and patient care, positioning Applied Proteomics as a leader in proteomic diagnostics.
